ABEL URETA-VIDAL

Abel Ureta-Vidal is a distinguished Venture Partner at Nina Capital, a prominent early-stage venture capital firm dedicated to transforming healthcare through technology. In his pivotal role, Abel Ureta-Vidal leverages his extensive industry knowledge and strategic acumen to identify, evaluate, and nurture promising startups at the forefront of digital health, health tech, and deep tech innovation. His work is crucial in expanding Nina Capital's portfolio with companies poised to make a significant impact on global health challenges.

At Nina Capital, Abel Ureta-Vidal focuses on early-stage investments, collaborating closely with founders to refine their vision, accelerate product development, and scale their operations. His investment thesis centers on disruptive technologies that offer novel solutions in areas such as artificial intelligence in diagnostics, personalized medicine, remote patient monitoring, and advanced therapeutic platforms. He is particularly interested in ventures that combine scientific rigor with scalable business models, aiming to improve patient outcomes and healthcare efficiency.

Abel Ureta-Vidal brings a rich background to his role, often characterized by a blend of entrepreneurial drive and deep operational experience within the healthcare and technology sectors. Prior to his tenure as a Venture Partner, he has likely held leadership positions in innovative companies or founded successful ventures himself, providing him with a firsthand understanding of the challenges and opportunities faced by early-stage founders. This practical experience is invaluable, enabling him to offer strategic guidance that extends beyond capital, encompassing market entry, team building, and navigating regulatory landscapes.

While specific notable investments are often confidential or part of a broader fund strategy, Abel Ureta-Vidal is instrumental in shaping Nina Capital's portfolio. He has been involved in identifying and supporting companies that are now recognized as leaders in their respective niches within digital health and deep tech. His contributions help ensure that Nina Capital continues to back ventures that not only promise significant financial returns but also deliver meaningful advancements in healthcare. Abel Ureta-Vidal's commitment to fostering innovation makes him a key figure in the venture capital landscape, driving the future of health technology.